The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) for the treatment of pediatric patients (aged one to 11 years) with eosinophilic esophagitis (EoE).
Jan 30, 2024
0
7
For extremely preterm infants, the risk for death or moderate or severe bronchopulmonary dysplasia is not significantly lower among those receiving early treatment for patent ductus arteriosus (PDA) with ibuprofen versus ...
Jan 25, 2024
0
0
A new study at the University of Missouri's Thompson Center for Autism and Neurodevelopment has found that propranolol, a medication that treats high blood pressure, can also help lower anxiety for kids and young adults with ...
Jan 23, 2024
0
1
Placebos have been studied more than any treatment in the history of medicine, yet they remain mysterious.
Jan 22, 2024
0
32
For adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in the Jan. 18 issue of the New England ...
Jan 18, 2024
0
0
A large randomized control trial conducted by a team of Neuroscience Research Australia (NeuRA) and UNSW researchers found that at-home 'gamified' step exercises were effective at preventing falls in people over the age of ...
Jan 17, 2024
1
87
Acoramidis yields a significantly better four-step primary hierarchical outcome, including aspects of mortality and morbidity, than placebo for patients with transthyretin amyloid cardiomyopathy, according to a study published ...
Jan 14, 2024
0
6
For heavily transfused patients with lower-risk myelodysplastic syndromes (LR-MDS) who are not responding to or are ineligible for erythropoiesis-stimulating agents (ESAs), the competitive telomerase inhibitor imetelstat ...
Jan 9, 2024
0
0
For children with achondroplasia, vosoritide is associated with a gain in the change in height Z score from baseline and a mild adverse event profile, according to a study published in the January issue of The Lancet Child ...
Dec 30, 2023
0
0
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rebound occurs at a similar rate for those receiving and not receiving oral antiviral treatment and for those receiving nirmatrelvir/ritonavir or placebo, according ...
Dec 22, 2023
0
0
